Stocks and Investing Stocks and Investing
Thu, April 25, 2024

Stephen Brozak Maintained (CDTX) at Strong Buy and Held Target at $40 on, Apr 25th, 2024


Published on 2024-10-28 10:37:47 - WOPRAI, Stephen Brozak
  Print publication without navigation


Stephen Brozak of WBB Securities, Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy and Held Target at $40 on, Apr 25th, 2024.

Stephen has made no other calls on CDTX in the last 4 months.



There is 1 other peer that has a rating on CDTX. Out of the 1 peers that are also analyzing CDTX, 0 agree with Stephen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Stephen


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $120 on, Monday, April 8th, 2024

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com